AOTMiT: Transparency Council on plasmocytic myeloma, hemiplegia and familial hypercholesterolemia, among others

The agenda includes:

1. Prepare an opinion on the draft Health Prevention Program "Prevention of depressive disorders for children and adolescents aged 10- 19 years in the city of Krosno for 2027- 2028".

2 Prepare an opinion on the draft "Health policy program on the prevention of overweight and obesity and postural defects among children in the third grade of elementary school in the city of Elk for 2024-2028".

3 Prepare a position on the qualification of the health care service "Screening for familial hypercholesterolemia implemented as part of the balance examination performed at the stage of annual mandatory preschool preparation" as a guaranteed benefit.

4 Prepare a position paper on the reimbursement of Luxturna (voretigene neparvovec) under the drug program "Treatment for Leber congenital blindness (LCA) with biallelic mutation of the RPE65 gene (ICD-10: H35.5)".

5 Prepare a position paper on the reimbursement of Voxzogo (vosoritidum) under the drug program "Treatment of patients with achondroplasia (ICD-10: Q77.4)".

6. Prepare a position paper on the reimbursement of Shingrix herpes zoster vaccine (recombinant, with adjuvant) for the indication: prevention of herpes zoster and hemiplegic neuralgia in persons 18 years of age and older with an increased risk of developing herpes zoster.

7 Prepare a position paper on reimbursement of Elrexfio (elranatamabum) under drug program B.54. "Treatment of patients with plasmocytic myeloma (ICD- 10: C90.0)".

8 Prepare a position paper on the reimbursement of Filsuvez (betulae cortex extractum) for the indication: treatment of wounds of partial thickness associated with the dystrophic and borderline forms of bullous epidermal separation in patients aged 6 months and older.

9. Prepare a position on the target import of Mexiletine for the indications: myotonic dystrophy type I; myotonic dystrophy type II; myotonic syndrome; Becker's myotonia; Thomsen's myotonia; congenital paramyotonia; hyperkalemic periodic paralysis; paramyotonic periodic paralysis; ventricular arrhythmias; paroxysmal atrial fibrillation; recurrent electrical storms; prolonged QT syndrome.

10. Prepare an opinion on the draft Health Prevention Program "Prevention of incontinence among female residents of Poznań aged 30+ for 2025-2027".

Source: AOTMiT